Fund overview & performance

Looking for segregated funds?

Canada Life Segregated Funds

Canada Life Global Equity Fund F5

April 30, 2026

The Fund seeks to provide long-term capital growth by investing in equity securities of companies anywhere in the world

Is this fund right for you?

  • You want your money to grow over a longer term.
  • You want to invest in global equities with less volatility.
  • You're comfortable with a medium level of risk.

RISK RATING

Risk Rating: Moderate

How is the fund invested? (as of February 28, 2026)

Asset allocation (%)
Name Percent
US Equity 61.7
International Equity 34.4
Cash and Equivalents 3.9
Geographic allocation (%)
Name Percent
United States 61.7
United Kingdom 7.9
Japan 5.5
France 4.9
Canada 3.9
Germany 2.9
Taiwan 2.8
Switzerland 2.3
Ireland 2.1
Other 6.0
Sector allocation (%)
Name Percent
Technology 26.8
Financial Services 15.9
Healthcare 9.6
Industrial Goods 9.3
Consumer Services 8.8
Consumer Goods 7.8
Industrial Services 5.3
Energy 5.0
Cash and Cash Equivalent 3.9
Other 7.6

Growth of $10,000 (since inception)

Period:

For the period 07/12/2016 through 04/30/2026 tr.with $10,000 CAD investment, The value of the investment would be $20,762

Fund details (as of February 28, 2026)

Top holdings (%)
Top holdings Percent (%)
NVIDIA Corp 4.8
Apple Inc 4.6
Cash and Cash Equivalents 3.9
Alphabet Inc Cl A 3.6
Microsoft Corp 3.1
Johnson & Johnson 2.8
JPMorgan Chase & Co 2.8
Taiwan Semiconductor Manufactrg Co Ltd - ADR 2.8
Philip Morris International Inc 2.5
Amazon.com Inc 2.2
Total allocation in top holdings 33.1
Portfolio characteristics
Portfolio characteristics Value
Standard deviation 8.9%
Dividend yield 1.6%
Yield to maturity -
Duration (years) -
Coupon -
Average credit rating Not rated
Average market cap (million) $1,348,051.7

Understanding returns

Annual compound returns (%)

Short term
1 MO 3 MO YTD 1 YR
3.9 0.8 2.1 17.1
Long term
3 YR 5 YR 10 YR INCEPTION
14.0 11.0 - 7.7

Calendar year returns (%)

2025 - 2022
2025 2024 2023 2022
13.8 22.4 8.4 -2.8
2021 - 2018
2021 2020 2019 2018
15.6 0.5 12.0 0.6

Range of returns over five years (August 01, 2016 - April 30, 2026)

Best return / Worst return
Best return Best period end date Worst return
Worst period end date
12.7% Oct 2025 4.0% Jun 2022
Summary
Average return % of periods with positive returns Number of positive periods Number of negative periods
7.4% 100 58 0

Q1 2026 Fund Commentary

Commentary and opinions are provided by Mackenzie Investments.

Market commentary

The global economy navigated a turbulent first quarter. Markets began 2026 on a positive note, with investor sentiment buoyed by continued disinflation, stable corporate earnings and expectations for further monetary easing. The outlook shifted dramatically in late February after the conflict in the Middle East escalated, and the Strait of Hormuz was effectively closed in early March, disrupting a significant share of global oil supply and raising fears of an energy-driven inflation shock.

Major central banks responded with caution. The U.S. Federal Reserve Board and the Bank of Canada both held rates unchanged at their January and March meetings. The European Central Bank postponed planned interest rate reductions and raised its inflation forecast after energy prices surged. These developments signaled that monetary easing cycles could be delayed or disrupted by the geopolitical shock.

Global equity markets declined in the first quarter, with the MSCI World Index falling about 3.5%. The U.S. market weighed most heavily on results as large-cap technology stocks retreated amid rising inflation concerns. Japanese equities benefited from ongoing corporate governance reforms. Emerging markets ended the quarter roughly flat, as higher import costs in oil-importing economies in Asia partly offset gains in commodity-exporting markets.

Performance

Stock selection in the health care sector was the largest contributor to the Fund’s performance. Overweight allocations to the energy and consumer staples sectors also contributed to performance.

Johnson & Johnson contributed to performance as investors rotated toward defensive, large-capitalization health care names with visible earnings and lower macroeconomic sensitivity. Confidence improved around the company’s ability to manage its patent transition, supported by continued strength in oncology and steady growth in medical technology. Exxon Mobil Corp. also contributed to performance as shifting commodity market expectations and ongoing geopolitical tensions supported energy prices. The company also benefited from record upstream production driven by its Permian Basin and Guyana operations.

Stock selection in the energy and materials sectors detracted from performance.

SAP SE detracted from performance because of broad investor concerns about artificial intelligence (AI) disruption in the software sector, despite solid underlying results. In the sub-advisor’s view, the weakness was driven more by sentiment than by fundamentals, with cloud revenue continuing to grow and better-than-expected guidance issued for the year ahead. Microsoft Corp. also detracted from performance as cloud revenue growth fell short of investor expectations, partly because of internal demand for computing capacity as the company balanced external deployment with developing its own artificial intelligence offerings.

Portfolio activity

The sub-advisor added The Phillips 66 Co. to the Fund. The company is a leading North American downstream energy business, and improving refining margins driven by volatility in global energy markets supported the investment case. The sub-advisor also added Reckitt Benckiser Group PLC. The company has simplified its business by focusing on core brands in household care, germ protection and self-care, which in the sub-advisor’s view should support long-term growth.

Diageo PLC was sold. While the sub-advisor continues to view the company as high quality, a recent leadership change signaled a strategic shift away from premiumization, which changed the investment case. The sub-advisor also sold Uber Technologies Inc., taking advantage of early-quarter volatility to redeploy capital into what the sub-advisor believes are more attractive opportunities.

Period:
Chart type:
* Must be between 1 and 50
Canada Life Global Equity Fund F5

Canada Life Global Equity Fund F5

Period:
Interval:
Export to: Export to CSV file
ID Effective date Price ($) Income Capital gain Total distribution